[Value of a new non-ionic contrast medium, iopromide 300 in renal arteriography using an arterial route. Comparative study with ioxaglate 320 mgI/ml].
Thirty-nine patients with hypertension were included in a prospective randomized trial comparing two contrast media in intra arterial digital subtraction arteriography of renal arteries. Efficacy and safety were evaluated for a new non-ionic contrast medium, iopromide 320 and the ionic low-osmolar medium, ioxaglate 320 mgI/ml. We have been able to show a statistically significant difference between these two products: iopromide 370 is, in this situation, less painful than ioxaglate 320 mgI/ml.
Laval-Jeantet
M
M
Martin-Bouyer
Y
Y
D015901:Angiography, Digital Subtraction; D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006973:Hypertension / Q000000981:diagnostic imaging; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012077:Renal Artery / Q000000981:diagnostic imaging*
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D007485:Ioxaglic Acid
Intérêt d'un nouveau produit de contraste non ionique, l'iopromide 370 en artériographie rénale par voie artérielle. Etude comparative avec l'ioxaglate 320 mgI/ml.